Review summary
Teaching objective: Evaluate a 50-year-old researcher with a year of insomnia and poor appetite, weeks of near-sleeplessness, and suspicious thoughts about colleagues, who heats mercury and other metals in an unventilated laboratory: an occupational and exposure history; examination for tremor, gingivitis, and erethism; blood mercury, 24-hour urine mercury (with creatinine correction), and blood lead interpreted against ATSDR guidance without overclaiming causation; kidney function and urine protein; removal from exposure and a workplace hazard assessment against the NIOSH and OSHA limits; ACMT guidance against provoked urine testing and against chelation for low-level exposure; a DSM-5-TR differential of major depression with or without psychotic features, delusional disorder, and a substance- or toxin-induced disorder; suicide and violence risk assessment with means safety and the 988 Lifeline; CBT for insomnia; and measurement-based treatment of depression with an SSRI and psychotherapy (APA 1686, VA/DoD 1689, CMID depression monograph).
Historical timeline
| Date | Event | Claims |
|---|---|---|
| 4 January 1643 (25 December 1642, Julian) | Born at Woolsthorpe, Lincolnshire; his father had died before his birth. | CLM-0001 |
| 1667 | Fellow of Trinity College, Cambridge; Lucasian Professor from 1669; Fellow of the Royal Society from 1672. | CLM-0002 |
| Autumn 1692 (Julian) | Loss of appetite and want of sleep begin, by his biographer's account. | CLM-0004 |
| December 1692 to January 1693 (Julian) | Deeply engaged in chemical experiments. | CLM-0003 |
| 23 September 1693 (13 September 1693, Julian) | Writes to Pepys of his distress, poor sleep and appetite, and his withdrawal from friends. | CLM-0005 |
| 26 September 1693 (16 September 1693, Julian) | Writes to Locke retracting his suspicions and asking forgiveness. | CLM-0006 |
| 8 October 1693 (28 September 1693, Julian) | Tells a friend at Huntingdon that a distemper kept him awake five nights; apologizes to Pepys through him. | CLM-0007 |
| 25 October 1693 (15 October 1693, Julian) | Explains to Locke that he had barely slept for a fortnight. | CLM-0008 |
| 29 May 1694 | A second-hand report of insanity noted by Huygens; later disputed. | CLM-0009 |
| 1699 | Master of the Mint; later President of the Royal Society. | CLM-0014 |
| 1703 | Locke describes him as apt to raise suspicions where there is no ground. | CLM-0013 |
| 1722 | Urinary incontinence; a bladder stone passed in 1724. | CLM-0015 |
| 31 March 1727 (20 March 1726/7, Julian) | Dies at Kensington of a bladder stone, aged 84. | CLM-0016 |
| 1979 to 2008 | Retrospective proposals of mercury poisoning, manic-depressive illness, and Asperger's syndrome; all disputed. | CLM-0010, CLM-0011, CLM-0012 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Isaac Newton was born at Woolsthorpe, in the parish of Colsterworth, Lincolnshire, on Christmas Day 1642 (25 December 1642 in the Julian calendar then used in England; 4 January 1643 in the Gregorian calendar), the only son of Isaac, a farmer, and his wife Hannah Ayscough. His father died before he was born, and his mother later remarried and had three more children. Family history; the cause of his father's death is not recorded in the cited source. |
confirmed | Sir Isaac Newton supports Longstaff A. Calendars from around the world context |
| D | He was educated at Grantham and at Trinity College, Cambridge, became a Fellow of Trinity in 1667, held the Lucasian Professorship of Mathematics from 1669 to 1702, and was elected a Fellow of the Royal Society in 1672. | confirmed | Sir Isaac Newton supports |
| D | His biographer David Brewster, working from Newton's manuscripts, wrote that he was deeply engaged in chemical experiments in December 1692 and January 1693. Among his papers is a one-page manuscript in his hand titled 'Notes on mercury and its purification'. His alchemical work with metals, including mercury, is documented; the amount of mercury he breathed or handled is not. |
confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports Newton I. Notes on mercury and its purification (catalogue entry ALCH00120) supports |
| D | Brewster wrote that from the autumn of 1692 Newton complained of loss of appetite and want of sleep, which continued for nearly a twelvemonth. A nineteenth-century biographer's summary drawn from the letters that follow. |
confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports |
| D | On 13 September 1693 (Julian; 23 September, Gregorian) Newton wrote to Samuel Pepys that he was 'extremely troubled at the embroilment I am in, and have neither ate nor slept well this twelvemonth, nor have my former consistency of mind', that he had never designed to get anything by Pepys's interest or the King's favour, and that he must withdraw from Pepys's acquaintance and see neither him nor the rest of his friends any more. His own words; they record poor sleep and appetite, distress, and withdrawal, not a diagnosis. |
confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports Powell B. Review of recent books on Newton (1856) supports |
| D | On 16 September 1693 (Julian; 26 September, Gregorian), writing from the Bull in Shoreditch, London, he told John Locke that, being of opinion that Locke had endeavoured to embroil him with women and by other means, he had answered, when told Locke was sickly and would not live, that 'twere better if you were dead'. He begged Locke's pardon for this, for representing that Locke's book struck at the root of morality and taking him for a Hobbist, and for saying or thinking that there was a design to sell him an office or to embroil him; he signed himself Locke's 'most humble and unfortunate servant'. The letter records suspicions of a friend that he then retracted, and an apology; no threat or act of harm is recorded. |
confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports Powell B. Review of recent books on Newton (1856) supports Goldie M. Isaac Newton and John Locke: in public and in private supports |
| D | John Millington of Magdalene College wrote to Pepys on 30 September 1693 (Julian) that he had met Newton at Huntingdon on the 28th, when Newton, of his own accord, said he had written Pepys 'a very odd letter', in 'a distemper that much seized his head, and that kept him awake for above five nights together', and asked Millington to beg Pepys's pardon. Millington judged him now very well, though 'under some small degree of melancholy', with no reason to suspect that it had touched his understanding. A friend's contemporary report of insomnia, low spirits, and apology. |
confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports Powell B. Review of recent books on Newton (1856) supports |
| D | Locke replied from Oates on 5 October 1693 (Julian) that he forgave Newton freely and fully. Newton answered from Cambridge on 15 October 1693 (Julian; 25 October, Gregorian) that the previous winter, by sleeping too often by his fire, he had got an ill habit of sleeping, that a distemper which that summer had been epidemical had put him further out of order, and that when he wrote he had not slept an hour a night for a fortnight together, and for five days together not a wink; he did not remember what he had said of Locke's book. His own account of severe insomnia. |
confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports Powell B. Review of recent books on Newton (1856) supports |
| D | The scientist Christiaan Huygens noted on 29 May 1694 that a Scotsman had told him that some eighteen months earlier Newton had become insane, from too intense application to his studies or from grief at losing his laboratory and manuscripts to fire, and that his friends had cared for him at home until he recovered. Brewster rejected the story, pointing to the letters and scholarly work Newton produced during that time. A second-hand report noted in a private journal; its claims of insanity and confinement are not corroborated by the letters and are disputed by later biographers. |
confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports |
| R | Brewster, in his 1855 biography, argued that Newton's mind was never in a state of derangement during 1692 and 1693; a reviewer of the following year judged that his own letters placed beyond doubt an illness that lamentably shook his nerves and, for a time, interfered with the coherent exercise of his faculties. Nineteenth-century interpretations, opposed to each other. |
disputed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XVII supports Powell B. Review of recent books on Newton (1856) supports |
| R | In 1979 two papers in Notes and Records of the Royal Society proposed that mercury poisoning from his chemical and alchemical experiments explained his illness of 1692 and 1693: Johnson and Wolbarsht called it a probable cause of his physical and mental ills, and Spargo and Pounds reported that hairs attributed to him contained several heavy metals, including mercury, at concentrations much higher than in modern hair, which they offered as circumstantial evidence for the hypothesis. A retrospective hypothesis; the provenance and dating of the hair are uncertain and the evidence is circumstantial. |
disputed | Johnson LW, Wolbarsht ML. Mercury poisoning: a probable cause of Isaac Newton's physical and mental ills. Notes Rec R Soc Lond 1979;34(1):1-9. PMID 11610639 supports Spargo PE, Pounds CA. Newton's 'Derangement of the Intellect'. New Light on an Old Problem. Notes and Records of the Royal Society of London 1979;34(1):11-32 (archive item 59) supports Emeritus Associate Professor Peter E Spargo: 1937-2021 supports |
| R | Other writers proposed manic-depressive illness rather than mercury poisoning (Lieb and Hershman, 1983). In 2008 Milo Keynes argued that the madness of 1692 and 1693 was due to mercury poisoning and not to clinical depression, and that Newton's lifelong distrust of others followed from his separation from his mother in childhood and not, as had been claimed, from Asperger's syndrome. Competing retrospective interpretations; none can be tested, and none is used as a diagnosis in this record. |
disputed | Lieb J, Hershman D. Isaac Newton: mercury poisoning or manic depression? Lancet 1983;2(8365-66):1479-80. PMID 6140563 supports Keynes M. Balancing Newton's mind: his singular behaviour and his madness of 1692-93. Notes Rec R Soc Lond 2008;62(3):289-300. PMID 19244857 supports |
| D | Locke remarked in 1703 that he had several reasons to think Newton truly his friend, but that he was 'a nice man to deal with, and a little too apt to raise in himself suspicions where there is no ground'. A friend's later description of his temperament. |
confirmed | Goldie M. Isaac Newton and John Locke: in public and in private supports |
| D | Newton became Master of the Mint in 1699 and was President of the Royal Society from 1705 to 1727. | confirmed | Sir Isaac Newton supports |
| D | In 1722, in his eightieth year, he was seized with incontinence of urine, first ascribed to the stone and thought incurable, then attributed to a weakness of the bladder sphincter; his physician advised him to give up his carriage and dining out and to eat simply. In August 1724 he passed, without pain, a stone about the size of a pea, in two pieces some days apart; John Conduitt noted that he had voided two stones as big as a pea. | confirmed | Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XXVI supports Conduitt J. Eye-witness account of Newton's death (c. 1727-8; King's College, Cambridge, Keynes Ms. 130.15) supports |
| D | He fell ill on 3 March 1727 (Julian) after a visit to London. When John Conduitt learned of it on 11 March he sent for Dr Richard Mead and the surgeon William Cheselden, who pronounced the disease to be stone in the bladder and held out no hope of recovery. He had severe fits of pain, seemed easier on 15 March, became insensible on the evening of the 18th, and died at about one in the morning of Monday 20 March 1726/7 (Julian; 31 March 1727, Gregorian) at Kensington, aged 84, unmarried. He was buried in Westminster Abbey on 28 March (Julian). Conduitt's eyewitness notes and Brewster's account, which draws on them. |
confirmed | Conduitt J. Eye-witness account of Newton's death (c. 1727-8; King's College, Cambridge, Keynes Ms. 130.15) supports Brewster D. Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton, vol. 2 (Edinburgh, 1855), Chapter XXVI supports Sir Isaac Newton supports Longstaff A. Calendars from around the world context |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | A year of poor sleep and poor appetite with 4 kg weight loss, two weeks of near-total sleeplessness, low spirits, and suspicious thoughts that colleagues and friends were plotting against him, now partly doubted; under evaluation for depression, a toxic cause, and other medical causes | resolved | confirmed | active | CLM-0004, CLM-0005, CLM-0006 |
| S | Occupational exposure to elemental and inorganic mercury, with lesser exposure to lead, antimony, and arsenic compounds, from heating metals in an unventilated private laboratory | active | confirmed | active | CLM-0003 |
| S | Major depressive disorder, single episode, severe, without psychotic features (PHQ-9 20 at intake): a year of poor sleep and appetite with weight loss, low mood, poor concentration, and suspicious ideas held with partial insight; medical causes excluded; the contribution of low-level mercury exposure is uncertain | active | confirmed | both_with_link | CLM-0004, CLM-0005, CLM-0007 |
| S | Chronic insomnia comorbid with depression: sleep onset and maintenance difficulty for a year, with two weeks of near-total sleeplessness before intake | active | confirmed | active | CLM-0004, CLM-0005 |
| S | Raised urine mercury from occupational exposure (24-hour urine 46 ug/L, 41 ug/g creatinine; blood 9.4 ug/L) without tremor, gingivitis, erethism, neuropathy, or kidney injury; below the levels linked to overt toxicity | active | confirmed | active | CLM-0003 |
| S | Acute viral upper respiratory infection (common cold) with a low-grade fever, sore throat, and cough, a week after starting sertraline; resolved | resolved | confirmed | active | CLM-0008 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1693-09-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 20 | http://loinc.org · 44261-6 |
| S | 1693-09-28 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 11 | http://loinc.org · 70274-6 |
| S | 1693-09-28 | Total score [MoCA] | 27 | http://loinc.org · 72172-0 |
| S | 1693-09-28 | Hemoglobin [Mass/volume] in Blood | 14.6 g/dL Reference 13.2-16.6 g/dL |
http://loinc.org · 718-7 |
| S | 1693-09-28 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 91 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 1693-09-28 | Leukocytes [#/volume] in Blood by Automated count | 6.1 10*3/uL Reference 3.4-9.6 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1693-09-28 | Platelets [#/volume] in Blood by Automated count | 242 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1693-09-28 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1693-09-28 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1693-09-28 | Urea nitrogen [Mass/volume] in Serum or Plasma | 15 mg/dL Reference 8-24 mg/dL |
http://loinc.org · 3094-0 |
| S | 1693-09-28 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 1693-09-28 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1688)/1.73 sq M | 101 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1693-09-28 | Glucose [Mass/volume] in Serum or Plasma | 88 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1693-09-28 | Calcium [Mass/volume] in Serum or Plasma | 9.5 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 1693-09-28 | Albumin [Mass/volume] in Serum or Plasma | 4.2 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 1693-09-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 1693-09-28 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 mIU/L Reference 0.4-4 mIU/L |
http://loinc.org · 3016-3 |
| S | 1693-09-28 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 455 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 1693-09-28 | Albumin/Creatinine [Mass Ratio] in Urine | 9 mg/g{creat} Reference <=30 mg/g{creat} |
http://loinc.org · 9318-7 |
| S | 1693-09-28 | Mercury [Mass/volume] in Blood | 9.4 ug/L (high) Reference 95th percentile of US adults below 5 ug/L (ATSDR); 50 ug/L or more is the threshold for symptoms of toxicity |
http://loinc.org · 5685-3 |
| S | 1693-09-28 | Lead [Mass/volume] in Blood | 2.4 ug/dL Reference Below 3.5 ug/dL (CDC blood lead reference value) |
http://loinc.org · 5671-3 |
| S | 1693-09-28 | Mercury [Mass/volume] in 24 hour Urine | 46 ug/L (high) Reference Background below 2 ug/L (95th percentile of adults); below 20 ug/L not associated with effects (ATSDR) |
http://loinc.org · 21383-5 |
| S | 1693-09-28 | Mercury/Creatinine [Mass Ratio] in 24 hour Urine | 41 ug/g{creat} (high) Reference Occupational biological exposure index 20 ug/g creatinine |
http://loinc.org · 26688-2 |
| S | 1693-10-08 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 19 | http://loinc.org · 44261-6 |
| S | 1693-10-22 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | http://loinc.org · 44261-6 |
| S | 1693-10-22 | Cholesterol [Mass/volume] in Serum or Plasma | 176 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 1693-10-22 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 61 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 1693-10-22 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 98 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 1693-10-22 | Triglyceride [Mass/volume] in Serum or Plasma | 86 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 1693-10-29 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | http://loinc.org · 44261-6 |
| S | 1693-10-29 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | http://loinc.org · 70274-6 |
| S | 1693-10-29 | Mercury [Mass/volume] in Blood | 3.1 ug/L Reference 95th percentile of US adults below 5 ug/L (ATSDR); 50 ug/L or more is the threshold for symptoms of toxicity |
http://loinc.org · 5685-3 |
| S | 1693-10-29 | Mercury [Mass/volume] in 24 hour Urine | 31 ug/L (high) Reference Background below 2 ug/L (95th percentile of adults); below 20 ug/L not associated with effects (ATSDR) |
http://loinc.org · 21383-5 |
| S | 1693-10-29 | Mercury/Creatinine [Mass Ratio] in 24 hour Urine | 27 ug/g{creat} (high) Reference Occupational biological exposure index 20 ug/g creatinine |
http://loinc.org · 26688-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1693-09-28 | Body height | 170 cm | 8302-2 | S |
| 1693-09-28 | Body weight | 64 kg | 29463-7 | S |
| 1693-09-28 | Body mass index (BMI) [Ratio] | 22.1 kg/m2 | 39156-5 | S |
| 1693-09-28 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1693-09-28 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1693-09-28 | Heart rate | 84 /min | 8867-4 | S |
| 1693-09-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 1693-09-28 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1693-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1693-10-08 | Body height | 170 cm | 8302-2 | S |
| 1693-10-08 | Body weight | 63.8 kg | 29463-7 | S |
| 1693-10-08 | Body mass index (BMI) [Ratio] | 22.1 kg/m2 | 39156-5 | S |
| 1693-10-08 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 1693-10-08 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1693-10-08 | Heart rate | 80 /min | 8867-4 | S |
| 1693-10-08 | Respiratory rate | 14 /min | 9279-1 | S |
| 1693-10-08 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1693-10-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1693-10-15 | Body height | 170 cm | 8302-2 | S |
| 1693-10-15 | Body weight | 63.9 kg | 29463-7 | S |
| 1693-10-15 | Body mass index (BMI) [Ratio] | 22.1 kg/m2 | 39156-5 | S |
| 1693-10-15 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 1693-10-15 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1693-10-15 | Heart rate | 90 /min | 8867-4 | S |
| 1693-10-15 | Respiratory rate | 16 /min | 9279-1 | S |
| 1693-10-15 | Body temperature | 37.8 Cel | 8310-5 | S |
| 1693-10-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1693-10-22 | Body height | 170 cm | 8302-2 | S |
| 1693-10-22 | Body weight | 64.3 kg | 29463-7 | S |
| 1693-10-22 | Body mass index (BMI) [Ratio] | 22.2 kg/m2 | 39156-5 | S |
| 1693-10-22 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 1693-10-22 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1693-10-22 | Heart rate | 76 /min | 8867-4 | S |
| 1693-10-22 | Respiratory rate | 14 /min | 9279-1 | S |
| 1693-10-22 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1693-10-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1693-10-29 | Body height | 170 cm | 8302-2 | S |
| 1693-10-29 | Body weight | 64.8 kg | 29463-7 | S |
| 1693-10-29 | Body mass index (BMI) [Ratio] | 22.4 kg/m2 | 39156-5 | S |
| 1693-10-29 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 1693-10-29 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1693-10-29 | Heart rate | 72 /min | 8867-4 | S |
| 1693-10-29 | Respiratory rate | 14 /min | 9279-1 | S |
| 1693-10-29 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1693-10-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: professor of mathematics at a university college for about 25 years; for many years has also run a private chemistry laboratory in an outbuilding beside his college rooms, where he heats and distils metals and their ores in a furnace, often through the night
- S Exposure history: heats elemental mercury in open crucibles and makes amalgams with gold and other metals; roasts antimony ore and works with lead and, occasionally, arsenic sulfide in closed vessels; no fume hood, local exhaust, or respirator; spilled mercury is swept up with a brush; he eats and drinks at the bench; sessions of six to ten hours several nights a week; the last session was three days before this visit
- S Never married; lives alone in college rooms next to the laboratory; a small circle of friends and correspondents, from several of whom he has recently withdrawn
- S Never smoker; one glass of wine a week or less (AUDIT-C 1); no cannabis or other drugs; about four cups of tea a day; no supplements or folk remedies
- S No firearms; the laboratory holds mercury, arsenic, and other toxic chemicals
Functional status
- S Independent in all activities of daily living; still teaching, but has stopped answering letters, eats one small meal a day, and has spent nights at the furnace or lying awake
Mental status
- S Thin, slightly unkempt, tired; guarded at first, then courteous and engaged; speech normal in rate and volume; no psychomotor agitation or slowing
- S Mood "out of sorts and worn down"; affect constricted and anxious; thought process linear; preoccupied with the belief that a friend tried to entangle him in gossip and that others planned to buy him off with a post, which he now partly doubts ("I may have been unjust"); no fixed delusions; no hallucinations; no thoughts of death or self-harm; he once said in anger that a friend would be better dead, regrets it, and has no thoughts or intent of harming anyone; MoCA 27; insight partial and improving; judgment fair
Structured safety assessment
This assessment is synthetic and does not convert historical behavior into a present-day fact.
Allergies and medications
Allergies
- S No known allergy
Medications
- S Sertraline 50 mg oral tablet, one tablet by mouth each morning
- S Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for aches or fever, no more than 3 g a day
Procedures and immunizations
Procedures
Immunizations
- S 1687-06-15: Tdap vaccine
- S 1686-03-04: Hepatitis B vaccine, two-dose adult series completed
- S 1693-10-22: Influenza vaccine, 1693-1694 season
- S 1693-10-22: Pneumococcal conjugate vaccine PCV20
- S 1693-10-22: Recombinant zoster vaccine, dose 1 of 2
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D Autumn 1692 (Julian): Loss of appetite and want of sleep from the previous autumn, continuing for nearly a year, by his biographer's account (CLM-0004)
Family history
- D father: Died before the patient was born; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Toxic and other medical causes assessed by the second visit | 1693-10-08 | completed | Blood count, metabolic panel, TSH, vitamin B12, kidney tests, blood lead, and MoCA normal; blood and urine mercury raised from his work, below levels linked to overt toxicity |
| No further exposure to mercury and other metals until the laboratory is made safe | 1694-01-31 | active | Laboratory closed since intake; urine mercury falling |
| Response (PHQ-9 down by at least 50 percent) by eight to twelve weeks of treatment, then remission (PHQ-9 below 5) | 1693-12-31 | active | PHQ-9 14 after three weeks of sertraline, 30 percent below baseline |
| No suicidal thoughts and no thoughts of harming others | 1693-12-31 | active | None at any visit |
| At least six hours of sleep most nights without hypnotics | 1693-12-31 | active | About five and a half hours by the third chronic-care visit |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Workup for medical and toxic causes: blood count, metabolic panel, TSH, vitamin B12, MoCA, urine albumin-to-creatinine ratio and dipstick protein, blood mercury, 24-hour urine mercury with creatinine, and blood lead; examination for tremor, gingivitis, stomatitis, and neuropathy; no provoked (chelator-challenge) urine test and no broad metal screen | completed | GL-CMID-2026, GL-APA-DEP-2019, GL-MDD-2022, GL-ATSDR-HG-2018, GL-NIOSH-HG, GL-ACMT-2010, GL-ACMT-CHEL-2013 |
| Removal from exposure now: stop all heating of metals, close the laboratory, and do not sleep in the adjoining rooms until they are checked; the university environmental health and safety office to measure mercury vapor, decontaminate, and remove the mercury and arsenic compounds | completed | GL-ATSDR-HG-2018, GL-NIOSH-HG, GL-ACMT-2010, GL-ACMT-CHEL-2013 |
| Suicide and violence risk assessment with a safety plan: warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; toxic chemicals out of reach; safety reviewed at every visit | completed | GL-SUICIDE-2024, GL-CMID-2026 |
| Occupational and environmental medicine (medical toxicology) consultation on the meaning of the mercury results, chelation, the workplace hazard assessment, and a safe return to laboratory work | completed | GL-ATSDR-HG-2018, GL-NIOSH-HG, GL-ACMT-2010, GL-ACMT-CHEL-2013 |
| Sleep: cognitive behavioral therapy for insomnia (a fixed rising time, a sleep window, out of bed after 20 minutes awake, no dozing in the evening chair, no night work); no hypnotics or sedating antihistamines | completed | GL-ACP-INSOMNIA-2016 |
| Shared decision on depression treatment: sertraline 50 mg each morning with weekly cognitive behavioral therapy; PHQ-9 at every visit; an increase if the response is under 50 percent after six to eight weeks; continue for at least six to twelve months after remission | completed | GL-CMID-2026, GL-APA-DEP-2019, GL-MDD-2022, GL-DSM5TR-2022 |
| Collaborative care: the clinic's psychiatrist reviews his PHQ-9, safety, and medicine each week with the care manager, and sees him in person if psychotic features, suicidal thoughts, or thoughts of harming others appear, or if he does not respond | completed | GL-CMID-2026, GL-APA-DEP-2019, GL-MDD-2022 |
| Exposure follow-up: repeat 24-hour urine mercury and blood mercury four to six weeks after removal and again at three months; creatinine and urine albumin-to-creatinine ratio at three months; return to laboratory work only with a fume hood, a mercury spill kit, no food at the bench, and urine mercury below the biological exposure index | completed | GL-ATSDR-HG-2018, GL-NIOSH-HG, GL-ACMT-2010, GL-ACMT-CHEL-2013 |
| Nutrition: three regular meals a day, weight at every visit | completed | GL-CMID-2026, GL-APA-DEP-2019, GL-MDD-2022 |
Planned encounters
- 1693-09-28 — Primary care visit for a year of poor sleep and appetite, two weeks of near-sleeplessness, and suspicious thoughts about friends, in a researcher who heats mercury and other metals (ENC-001)
- 1693-10-08 — Ten-day review of metal and laboratory results, diagnosis, start of treatment, and occupational and environmental medicine consultation (ENC-002)
- 1693-10-15 — Same-day sick visit for a cold one week after starting sertraline (ENC-004, unscheduled)
- 1693-10-22 — Preventive health visit at 50 (ENC-005)
- 1693-10-29 — Three-week depression and exposure follow-up with a repeat 24-hour urine mercury (ENC-003)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Intermediate follow-up)
- Progress note 03 — Sick Visit
- Progress note 04 — Preventive Visit
- Progress note 05 — Focused Visit (Care-plan review)
- Occupational and Environmental Medicine (medical toxicology) referral
- Occupational and Environmental Medicine (medical toxicology) consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Intermediate follow-up) (XML)
- Progress note 03 — Sick Visit (XML)
- Progress note 04 — Preventive Visit (XML)
- Progress note 05 — Focused Visit (Care-plan review) (XML)
- Occupational and Environmental Medicine (medical toxicology) referral (XML)
- Occupational and Environmental Medicine (medical toxicology) consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the interpretation of the urine mercury result and the decision against chelation, the DSM-5-TR differential (no psychotic features), the suicide and violence screen, sertraline and CBT, CBT for insomnia, and the hazard assessment and return-to-work conditions. |
| provenance review | not_started | Brewster's 1855 biography, Baden Powell's 1856 review, and Conduitt's eyewitness account (Newton Project), Westminster Abbey, Mark Goldie's Oxford essay, the Trinity College archive record and a University of Cape Town obituary for the hair analysis, and three PubMed records logged. The 1979 Notes and Records papers and Westfall's biography could not be read in full. |
| safe messaging review | not_started | No suicidal thoughts in the synthetic episode; a documented angry remark about a friend is recorded as his own retracted words and handled as a violence screen with no intent. Claims about his mood, sleep, and suspicions are marked sensitive. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.